Test Price
1,400 AED✅ Home Collection Available
NIFTY Non-Invasive Prenatal Testing (NIPT) in UAE | 1800 AED
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed consultants.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
NIFTY NIPT (Non-Invasive Prenatal Testing) screens fetal cell-free DNA in maternal blood for trisomies 21, 18, 13 and select sex chromosome aneuploidies, offering expectant mothers a highly accurate, non-invasive alternative to traditional biochemical screening. This test is a leading choice for early pregnancy screening in the UAE, supported by internationally accredited laboratory processing.
| Feature | Our NIFTY NIPT Test | Closest Alternative (Combined First Trimester Screen) |
|---|---|---|
| Precision & Methodology | Next-Generation Sequencing (NGS) with >99.9% sensitivity for trisomy 21 | Biochemical markers (PAPP-A, free β-hCG) + nuchal translucency; ~85% sensitivity |
| Turnaround Time | 8–10 working days, direct laboratory integration | 10–14 days for combined risk calculation |
| Detection Scope | Trisomies 21, 18, 13, sex aneuploidies, and select microdeletions | Primarily trisomy 21 and 18; cannot resolve sex chromosome anomalies |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403:
“As a clinical geneticist, I emphasize that while NIPT provides exceptionally high negative predictive value, it remains a screening test and not a diagnostic confirmation; positive results must be followed by invasive testing such as amniocentesis or CVS for definitive karyotype. I encourage every patient to review their screening outcomes with a clinical geneticist or a fetal medicine specialist to fully understand the clinical context.”
Advisory – Medication & Clinical Notice
⚠ Important Medication & Clinical Notice
Do not discontinue prescribed medication without consulting your doctor. All clinical procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria & Emergency Red Flags
Test Not Advisable If:
- Multiple gestation beyond twins
- Known vanishing twin syndrome
- Maternal aneuploidy or malignancy
- Recent (< 3 months) blood transfusion or organ transplant
- BMI > 45 (may increase test failure rate)
Seek Emergency Care If You Experience:
- Heavy vaginal bleeding with clots
- Severe, persistent abdominal or pelvic pain
- Signs of miscarriage (passage of tissue, gush of fluid)
- Sudden decrease in fetal movement
- Severe headache or visual disturbances (rule out preeclampsia)
Patient FAQ & Clinical Guidance
1. How accurate is the NIFTY NIPT for detecting Down syndrome, and when should it be performed?
A: The NIFTY NIPT test demonstrates >99.9% sensitivity with a false positive rate below 0.1% for trisomy 21 when performed from 10 weeks gestation onward. For ideal results, we recommend scheduling the blood draw after an ultrasound confirms a viable, singleton pregnancy and clinical indications such as advanced maternal age or a high-risk first trimester screen are present.
2. Can NIFTY NIPT replace diagnostic procedures like amniocentesis?
A: NIFTY NIPT is a highly advanced screening tool but cannot replace invasive diagnostic tests because it analyzes placental cell-free DNA, which may occasionally differ from fetal karyotype due to confined placental mosaicism. A positive NIPT result must be confirmed by amniocentesis or chorionic villus sampling (CVS) before any irreversible clinical decision is made.
3. Does the 1800 AED NIFTY in UAE include home blood collection and genetic counseling?
A: The complete package at 1800 AED includes DHA-licensed home phlebotomy with a cold-chain transport kit, ISO-certified NGS analysis, and a post-result teleconsultation with a specialist in maternal-fetal medicine; genetic counseling for abnormal results is coordinated via our partner network at no extra cost. Insurance pre-approval can be verified instantly through our WhatsApp support line.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance
Your data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All laboratory operations comply with ISO 9001:2015 Certified (INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | NIFTY Non-Invasive Prenatal Testing (NIPT) |
| Price (AED) | 1,800 AED |
| Turnaround Time | 8–10 working days |
| Sample Type / Matrix | Maternal peripheral whole blood (plasma cell-free DNA) |
| Methodology Used | Next-Generation Sequencing (NGS) – Massive parallel sequencing of cfDNA |
| ICD-10-CM Code | Z36.8 (Encounter for antenatal screening of other condition) |
| LOINC Code | 82676-1 (Fetal cell-free DNA analysis) |
| DHA Facility License & Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ISO 9001:2015 Certified (INT/EGQ/2509DA/3139) | DHA Facility License 1143 | All rights reserved.
For clinical enquiries: +971 54 548 8731 | WhatsApp support available 8 AM – 11 PM
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians